Letter by rosenstein and parra regarding article, "greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel: Thrombolysis in myocardial infarction 38"

Robert S. Rosenstein, David Parra

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)e601
JournalCirculation
Volume119
Issue number25
DOIs
StatePublished - Jun 30 2009

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this